BioSpace News Archive

First Quarter Revenues of $8.6 Million Represented 32% Year-Over-Year Growth Driven by 28% Growth in Detection Revenue and 41% Growth in Therapy Revenue

Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the company’s selection for oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, being held virtually June 4-8, 2021.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) announced a Suspected Unexpected Serious Adverse Reaction (SUSAR) of hypotony (clinically-relevant decrease in ocular pressure) in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema (DME)

OPKO Health, Inc. reports business highlights and financial results for the three months ended March 31, 2021.

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the first quarter ended March 31, 2021,

Through ACC’s TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care

Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Vivlion GmbH, a company providing next-generation CRISPR gRNA libraries and screening services for the global R&D market, today announced a collaboration for the generation of gRNA libraries for CRISPR applications.

Cognoptix, a leading medical device/diagnostics company dedicated to the early detection of Alzheimer’s disease (AD), announced today that Dr. Susanne Wilke , the Company’s President and Chief Executive Officer, will present a “Spotlight Showcase” of Cognoptix under the title “Early-Stage Detection of Alzheimer’s Disease

Ocular Innovations, a Division of Engage Technologies Group, Inc. today announced it has launched their comprehensive, Optometric-exclusive video content library tailored for the Optometry industry that optimizes the overall Ocular patient experience.

Abiomed (NASDAQ:ABMD) announces the appointment of Paula A. Johnson, MD, MPH, to the Abiomed Board of Directors, effective immediately.